本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
Top 3 industry verticals fueling Singapore's cross-border growth are gaming, beauty, and fashion, which generated over US$1.6B1 in transaction value. Beyond the U.S., Singapore businesses are capturing new consumer demand in Mexico, where shoppers are turning to Singapore for beauty and fashion products. SINGAPORE, Nov. 11, 2025 /PRNewswire/ -- More than 90,000 Singapore-based businesses are selling internationally with PayPal. This represents one in four of Singapore's 356,1002 registered businesses, underscoring how digital commerce is powering global reach for local businesses. Collectively, over 14 million global customers shopped from businesses in Singapore using PayPal. Singapore Businesses Go Global: One in Four Sell Internationally with PayPal (PRNewsFoto/PayPal) The latest insights, based on a year of PayPal global cross-border transaction data 3, spotlights Singapore as a rising force in global digital commerce. With more than 60 million cross-border transactions processed during the period, the findings highlight the resilience and international relevance of Singapore businesses, particularly in high-growth verticals such as gaming, fashion, beauty, digital goods, and software. "PayPal continues to be a trusted partner for Singapore businesses expanding globally. Our brand gives international shoppers the confidence to buy across borders, and today, one in four local businesses sell internationally with PayPal. With our secure digital payment solutions and infrastructure, even the smallest business can reach customers around the world. For example, Singapore brands are gaining traction in high-growth markets such as Mexico, particularly in the beauty and fashion sectors. With product offerings like PayPal Ads and PayPal Rewards now available in selected international markets, we're helping local businesses grow their global customer base and build resilience in today's dynamic trade environment. We look forward to introducing even more solutions in 2026 to further simplify international expansion for businesses," said Matthew Lucas, Vice President and Head of Cross Border Trade at PayPal. Top 3 Verticals with the Highest Annual Transaction Value: Gaming, Beauty, and FashionSingapore's cross-border growth is being driven by three key sectors – gaming, beauty, and fashion – which together generated more than US $1.6 billion in transaction value. Gaming emerged as Singapore's most shopped cross-border category, generating more than US$593 million in transaction value and averaging 1.7 million transactions each month. The United States (U.S.) led as the top country buying from Singapore businesses with more than 500,000 monthly purchases, followed by Germany (230,000+), Japan (175,000+), the United Kingdom (100,000+), and France (84,000+), pointing to strong demand across developed economies. Beauty, Singapore's second strongest lifestyle export, generated over US$411 million in transaction value and averaged 898,000 monthly transactions. Demand was concentrated in emerging trade corridors such as Mexico with over 297,000 monthly purchases, followed by the United States (25,000+), Australia (21,000+), and China (16,000+). This mix shows the global appeal of Singapore's beauty and wellness brands, resonating well outside Asia in both niche and competitive markets. Fashion exports reached more than US$636 million in transaction value, averaging 737,000 monthly transactions. Demand was led by the United States (230,000+ monthly purchases), Mexico (194,000+), Japan (118,000+), and Germany (18,000+). From independent labels to established names, Singapore's fashion sector is finding loyal followings abroad across both developed economies and fast-growing corridors. In addition to these leading lifestyle exports, Singapore businesses are also building scale in digital goods, and in computers & software. Digital goods, spanning in-app purchases, subscriptions, and digital content, generated over US$276 million in transaction value with 665,000 monthly transactions on average, led by demand from the United States (254,000+ monthly purchases), Germany (92,000+) and Canada (34,000+). Together, these figures highlight the scalability of Singapore businesses and the critical role of trusted payment infrastructure in enabling their international growth. Diversification Beyond Traditional CorridorsWhile the United States remains Singapore's largest corridor, accounting for more than US$830 million in purchases, the latest insights show that Singapore businesses are increasingly tapping into new growth beyond traditional markets. Mexico has emerged as a fast-growing destination, with more than 7 million purchases worth over US$370 million, primarily in fashion and beauty. MethodologyThe insights in PayPal Global Beat 2025 are based on internal PayPal cross-border transaction data from April 1, 2024, to March 31, 2025. It examines trade flows from Singapore to international markets, analyzing transaction volumes and values across top verticals and buyer corridors. Discover more insights from PayPal Global Beat 2025 here. About PayPalPayPal has been revolutionizing commerce globally for more than 25 years. Creating innovative experiences that make moving money, selling, and shopping simple, personalized, and secure, PayPal empowers consumers and businesses in approximately 200 markets to join and thrive in the global economy. For more information, visit https://www.paypal.com, https://about.pypl.com, and https://investor.pypl.com. 1 Based on total transaction value of top 3 most shopped cross-border verticals for Singapore businesses: Gaming (US$593M+); Beauty (US$411M+); Fashion (US$636M+). PayPal Global Beat 2025 is available here2 Singapore Department of Statistics, 2025 3 PayPal Global Beat 2025 uncovers internal PayPal cross-border transaction data from April 1, 2024, to March 31, 2025 Media contacts:Prisita Menonprimenon@paypal.com Edelman for PayPalPayPalSGTeam@edelman.com
VxWave Ultrasound Imaging System demonstrated 94% scanning success rate and 100% data adequacy rate for vascular access creation strategies in CANSCAN trial New insights into vascular anatomy made possible by standardized image acquisition and reporting VxWave System has the potential to significantly advance standardization of vascular assessment at the point of care SYDNEY and SAN ANTONIO, Nov. 11, 2025 /PRNewswire/ -- Vexev, an Australian-based medical device company advancing next-generation vascular imaging, and U.S. Renal Care, a leading provider of in-center and home dialysis in the United States, announced the highly successful results of the CANSCAN Trial (NCT06691672), providing evidence that the VxWave Ultrasound Imaging System can reliably perform semi-autonomous vascular mapping examinations directly within the dialysis clinic. Dr. Varshi Broumand, CANSCAN Study Principal Investigator, presented the results during the American Society of Nephrology's annual meeting, Kidney Week 2025, in Houston, Texas (November 5-9). "Functioning vascular access is a lifeline for patients on hemodialysis, yet nearly 3 out of 4 arteriovenous fistulas (AVF) fail to mature or are abandoned before use. While traditional vascular mapping scans have improved vascular access, they suffer from poor patient compliance due to being scheduled outside of dialysis appointments, often lack standardized quality and are expensive," explained Dr. Broumand, Interventional Nephrologist at South Texas Renal Care Group. "The CANSCAN Trial highlights the potential that with the robotic VxWave System, we can finally bring high-quality vascular imaging on-demand in the dialysis clinic, overcoming barriers of cost, compliance, and variability that have limited patient outcomes for far too long." The first-of-its-kind, multi-center feasibility trial scanned 115 patients with severe kidney damage or end stage renal disease (CKD stage 4 and 5 patients) and the primary endpoints demonstrated: 94% Scan Completion Rate (SCR) 100% Data Adequacy Rate (DAR)1 98% of Access Options2 determined feasible in patients The VxWave System is a robotic tomographic ultrasound imaging system specifically designed for upper limb vascular imaging to be delivered on-demand at the point of care. The system integrates advanced robotics, machine learning and ultrasound signal processing to create a 3D vascular model and detailed report that aims to provide insights into vascular access points for hemodialysis. "The success of the CANSCAN Trial confirms that standardized, high-quality, point-of-care vascular assessment may now be achievable," said Shannon Thomas, MD, Chief Medical Officer, Vexev. "The trial represents a significant step towards the future of standardized vascular assessment across the globe, allowing us to plan vascular access for hemodialysis with data-driven precision, especially for higher risk patients whose anatomical factors may complicate traditional planning." Beyond providing evidence of feasibility, the CANSCAN trial provided insights into the upper limb vascular anatomy of CKD stage 4 and 5 patients and identified subgroups who may be at a disadvantage for vascular access creation. Specifically, patients with diabetes had significantly more calcification in the upper limb arteries and a reduction in forearm distal vascular diameters. Furthermore, female patients were found to have statistically fewer available veins and smaller veins overall compared to males. The VxWave system's potential ability to standardize examinations would allow dialysis clinics to better determine subgroups who may be at a disadvantage for vascular access creation, ultimately aiming to reduce the high rates of access failure and dialysis dysfunction currently experienced by patients. "This is one of the more promising innovations we've seen recently, and the results are encouraging," said Geoff Block, MD, FASN, Associate Chief Medical Officer and Senior Vice President, Clinical Research & Medical Affairs for U.S. Renal Care. "They suggest real potential to improve patient outcomes. As access expands, we're interested to see how an automated point-of-care imaging approach can enhance care across our network." About VexevVexev is an Australian med‑tech startup founded in 2018 by Dr. John Carroll and Dr. Eamonn Colley, experts in vascular fluid dynamics and computational imaging, dedicated to transforming blood-flow research into technology that improves vascular and renal health outcomes. Vexev is on a mission to improve lives by developing the next generation of vascular imaging solutions. Visit Vexev.com to learn more. About U.S. Renal CareU.S. Renal Care, the fastest-growing dialysis provider in the nation, partners with nephrologists across 32 states in the U.S. to care for more than 36,000 people living with kidney disease. Since 2000, U.S. Renal Care has been a leader in clinical quality, innovation, and operational excellence - delivering the best experience and outcomes for our patients. Visit USRenalCare.com to learn more. 1 The image quality of all successful scans was reviewed and deemed adequate by an independent panel of more than two vascular access specialists.2 Access options include arteriovenous graft (AVG) or arteriovenous fistula (AVF) Logo - https://mma.prnasia.com/media2/2738052/Vexev_Logo.jpg?p=medium600
Revenue reached $8.5 million, up 90% year over year; nine-month revenue totaled $25.8 million, representing 132% of full-year 2024 total revenue. Adjusted EBITDA was $1.0 million, an increase of 49% year over year; nine-month adjusted EBITDA reached $3.8 million, or 167% of full-year 2024 total. STUART, Fla., Nov. 11, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced its financial results for the third quarter ended September 30, 2025. Financial Highlights for the Third Quarter and Nine-Month of 2025: Billed Enrolled Employees. The number of billed enrolled employees (EEs) was 25,248, an increase of 7,654 EEs YoY. Distribution. The number of Brokers, Third-party Administrator ("TPAs") and Agencies expanded to 849 partners as of September 30, 2025, up 57% YoY. Revenues. Total revenues were $8.5 million, up 90% YoY; The first-nine months revenues of $25.8 million, 132% of full year 2024. Pre-tax income. Pre-tax income was $0.6 million, up 48% YoY; The first-nine months pre-tax income of $2.1 million, 238% of full year 2024. Adjusted EBITDA. Adjusted EBITDA was $1.0 million, up 49% YoY; The first-nine months adjusted EBITDA of $3.8 million, 167% of full year 2024. Cash. Cash balance was $8.0 million as of September 30, 2025. Accounts receivable, net. Accounts receivable balance was $0.9 million as of September 30, 2025, reduced $0.1 million YoY. Tim Johnson, CEO of Health In Tech, said:"Our third quarter highlights the accelerating strength of our distribution ecosystem and the solid foundation we've built this year. Revenue reached $8.5 million, up 90% year over year, bringing nine-month revenue to $25.8 million—already 132% of full-year 2024 revenue. This growth reflects the continued expansion of our broker, TPA, and agency network, which is now translating directly into sustained revenue momentum as our technology gains adoption across new distribution channels." He continued:"In September, we launched large-employer underwriting within eDIYBS, allowing brokers to generate quotes for groups of 150 or more employees in as little as two weeks—versus the industry timeline of often three months. This capability is a significant milestone, extending the speed and scalability of our small-business underwriting into the mid- and large-employer market. It marks a major step forward in how health plans are designed, quoted, and delivered at scale." Mr. Johnson added:"We also remain focused on solving one of the most costly inefficiencies in U.S. healthcare—claims administration, which costs the industry more than $300 billion annually. Our non-binding LOI with AlphaTON Capital marks a strategic step toward exploring blockchain-enabled solutions that can modernize this process. Together with AlphaTON and Brittany Kaiser's leadership in blockchain ethics and policy, we're developing HITChain—a decentralized, verifiable claims infrastructure designed to compress processing timelines, eliminate duplication, lower costs, and create a transparent system of record for all stakeholders. By combining insurance domain expertise with blockchain innovation, we're seeking to position Health In Tech at the frontier of decentralized healthcare infrastructure—a market opportunity of substantial scale and long-term impact." "We delivered another quarter of strong financial performance," said Julia Qian, CFO of Health In Tech. "Revenue grew 90% year over year and profit increased 48%, reflecting both operational strength and disciplined execution. We continue to balance growth with strategic investments in technology and enhanced platform capabilities—initiatives that reinforce our leadership position and support sustainable long-term performance." Recent Business Developments and Highlights eDIYBS Upgrade: Expanded HIT's Enhanced Do-It-Yourself Benefit System to serve 150+ employee groups. This upgrade significantly increases HIT's addressable market and accelerates large-group underwriting from months to about 2 weeks, extending the speed and scalability of our small-business underwriting into the mid- and large-employer market. It marks a major step forward in how health plans are designed, quoted, and delivered at scale. AlphaTON Capital: Signed a non-binding strategic LOI to co-develop HITChain, a blockchain-powered claims platform built on The Open Network (TON). The partnership positions HIT at the forefront of decentralized claims infrastructure, targeting efficiency gains in the $300B+ U.S. claims market. 2026 Davos Summit: Announced to host HIT's first Independent InsurTech Summit during the World Economic Forum week in Davos. The event will convene global leaders across insurance, healthcare, and technology. Two panels have been announced this quarter: "AI and Institutional Resistance - CEOs Driving Change in Legacy Sectors," featuring TIME CEO Jessica Sibley and HIT CEO Tim Johnson; and "First Ladies: Backing Women Who Build" featuring Cherie Blair CBE, KC, Founder of the Cherie Blair Foundation for Women. Additional panels will be announced in the coming months, highlighting HIT's expanding influence in shaping global industry dialogue. SIIA 2025 Conference: Showcased upgraded eDIYBS to thousands of industry leaders. The event expanded broker engagement and reinforced HIT's reputation as a leader in AI-powered self-funding solutions, demonstrating real-time quoting capabilities and platform flexibility. Conference Call Details Health In Tech will host a conference call to discuss the financial results for the Third quarter of 2025 on Nov 10, 2025, at 5:00 p.m. (ET). To participate in our live conference call and webcast, please dial 1-888-346-8982 or 1-412-902-4272 (for international participants). A live audio webcast will be available via the Investor Relations page of Health In Tech's website at https://healthintech.com/. A replay of the webcast will be available for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days. Non-GAAP Financial Information This release presents Adjusted EBITDA, a non-GAAP financial metric, which is provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). A reconciliation of historical non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release. Use of Forward‑Looking Statements Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity. About Health In Tech Health In Tech (Nasdaq: "HIT") is an Insurtech platform company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com. Health In Tech, Inc. Consolidated Statements of Operations （Unaudited） Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Revenues Revenues from underwriting modeling (ICE) $1,389,604 $1,528,451 $5,832,164 $4,952,191 Revenues from fees 7,100,489 2,930,470 19,986,762 9,634,151 SMR 7,100,489 2,250,549 19,986,762 7,379,016 HI Card - 679,921 - 2,255,135 Total revenues 8,490,093 4,458,921 25,818,926 14,586,342 Cost of revenues 3,346,277 979,628 9,009,841 2,944,266 Gross profit 5,143,816 3,479,293 16,809,085 11,642,076 Operating expenses Sales and marketing expenses 962,567 508,467 3,279,560 2,526,197 General and administrative expenses 3,451,907 1,813,520 10,474,125 5,629,393 Research and development expenses 235,819 718,424 1,356,149 2,180,246 Total operating expenses 4,650,293 3,040,411 15,109,834 10,335,836 Other income (expense): Interest income 111,699 38,460 305,263 94,111 Interest expenses - (165,000) - (495,000) Other income - 157,156 118,399 157,156 Other expense (5,000) (62,759) (5,000) (62,759) Total other income (expense), net 106,699 (32,143) 418,662 (306,492) Income before income tax expense $600,222 $406,739 $2,117,913 $999,748 Provision for income taxes (148,046) (30,653) (536,514) (185,119) Net income $452,176 $376,086 $1,581,399 $814,629 Net income per share Basic $0.01 $0.01 $0.03 $0.02 Diluted $0.01 $0.01 $0.03 $0.02 Weighted average common stocks outstanding Basic 56,432,407 51,769,358 55,484,860 51,769,358 Diluted 58,774,334 51,769,358 57,477,873 51,769,358 Health In Tech, Inc. Consolidated Balance Sheets (Unaudited) September 30, 2025 December 31, 2024 Assets Current assets Cash $8,023,613 $7,849,248 Accounts receivable, net 868,628 1,647,103 Other receivables 3,871,106 500,252 Deferred offering costs 166,012 - Prepaid expenses and other current assets 2,117,854 787,161 Total current assets 15,047,213 10,783,764 Non-current assets Software 6,182,691 3,962,461 Loans receivable, net 863,996 815,995 Operating lease - right of use assets 157,122 206,269 Long-term prepaid expenses 504,822 - Total non-current assets 7,708,631 4,984,725 Total assets $22,755,844 $15,768,489 Liabilities and stockholders' equity Current liabilities Accounts payable and accrued expenses $4,295,384 $1,858,840 Income taxes payable - 205,253 Operating lease liabilities - current 73,769 66,881 Other current liabilities 869,088 - Total current liabilities 5,238,241 2,130,974 Non-current liabilities Deferred tax liabilities 274,809 328,676 Operating lease liabilities - non-current 83,831 139,811 Total non-current liabilities 358,640 468,487 Total liabilities 5,596,881 2,599,461 Stockholders' equity Common stock, $0.001 par value; Class A Common stock 150,000,000 shares authorized, 44,785,771 and 42,914,870 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 44,785 42,915 Common stock, $0.001 par value; Class B Common stock 50,000,000 shares authorized, 11,700,000 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 11,700 11,700 Additional paid-in capital 11,579,683 9,173,017 Retained earnings 5,522,795 3,941,396 Total stockholders' equity 17,158,963 13,169,028 Total liabilities and stockholders' equity $22,755,844 $15,768,489 Health In Tech, Inc. Consolidated Statements of Cash Flows (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 CASH FLOWS FROM OPERATING ACTIVITIES: Net income $452,176 $376,086 $1,581,399 $814,629 Adjustments to reconcile net income to net cash provided by operating activities: Write-off of accounts receivable (4,089) - 1,901 - Amortization expense 217,981 135,584 489,947 405,158 Provision for refund liability 1,413,345 - 2,369,088 - Deferred tax expenses (benefits) 12,680 (27,676) (53,867) (86,992) Amortization of debt discount - 165,000 - 495,000 Interest income (16,003) (15,999) (48,001) (47,997) Stock-based compensation expense 292,552 - 1,493,686 - Changes in operating assets and liabilities: Accounts receivable, net 416,592 524,838 776,574 1,302,733 Other receivables (16,272) 546,645 (3,370,854) 1,166,017 Prepaid expenses and other current assets (486,424) (118,116) (690,665) (209,841) Long-term prepaid expenses 151,000 - (206,666) - Operating lease right of use assets and liabilities, net 18 624 55 1,871 Accounts payable and accrued expenses (224,639) 491,031 2,045,258 (1,064,527) Income taxes payable (34,944) 43,030 (205,253) (68,675) Other current liabilities (1,500,000) - (1,500,000) - Net cash provided by operating activities 673,973 2,121,047 2,682,602 2,707,376 CASH FLOWS FROM INVESTING ACTIVITIES: Development of software (744,841) (67,278) (2,358,213) (294,634) Net cash used in investing activities (744,841) (67,278) (2,358,213) (294,634) CASH FLOWS FROM FINANCING ACTIVITIES: Payments of deferred offering costs (43,685) (324,744) (150,024) (936,864) Repayments of notes payable - (2,145,000) - (2,145,000) Net cash used in financing activities (43,685) (2,469,744) (150,024) (3,081,864) Increase (decrease) in cash (114,553) (415,975) 174,365 (669,122) Cash, beginning of the period 8,138,166 2,163,203 7,849,248 2,416,350 Cash, end of the period 8,023,613 1,747,228 8,023,613 1,747,228 Supplemental disclosures of cash flow information: Cash paid for interest $- $- $- $- Cash paid for income taxes $198,000 $15,300 $823,323 $340,787 Summary of noncash investing and financing activities: Accrued deferred offering costs included in accounts payable and accrued expenses $55,827 $137,325 $55,827 $137,325 Accrued development of software included in accounts payable and accrued expenses $401,964 $126,977 $401,964 $126,977 Issuance of Class A common stock for future service $146,816 $- $1,184,800 $- Adjusted EBITDA Reconciliation (Unaudited) For Three Months Ended September 30, For Nine Months Ended September 30, 2025 2024 2025 2024 Net income $452,176 $376,086 $1,581,399 $814,629 Interest (income) expenses (111,699) 126,540 (305,263) 400,889 Depreciation and amortization 217,981 135,584 489,947 405,158 Income tax expense 148,046 30,653 536,514 185,119 Stock-based compensation expense 292,552 - 1,493,686 - Total net adjustments 546,880 292,777 2,214,884 991,166 Adjusted EBITDA $999,056 $668,863 $3,796,283 $1,805,795 Components of Operating Results Revenues While we generate our revenue primarily from small employers and insurance carriers, we grow our business primarily from offering solutions that streamline sales processes, enhance service delivery, and reduce the sales cycle duration for TPAs, MGUs, and Brokers. We offer our services through our three subsidiaries. Program services provided by SMR and MGU activities provided by ICE (including eDIYBS) are interdependent, as they cannot function effectively without being combined. Services provided by HI Card are an optional add-on to our other services, and cannot be offered on a standalone basis. Brokers that utilize the program services on behalf of the small employer provided by SMR and MGU activities provided by ICE, are not obligated to utilize our HI Card service. Currently ICE does not offer underwriting services as a standalone service. In the future, we may consider offering it as a standalone service. Cost of revenues Cost of revenues primarily consists of infrastructure costs to operate our platform such as hosting fees and fees paid to various third-party partners for access to their technology, services and amortization expenses of our capitalized internal-use software related to our platform. We mainly outsource captive management services and data services from the third-party companies. Our internal proprietary system seeks to consistently improve underwriting and services results through machine learning and data feeds. The captive management activities include introducing new carriers, conducting due diligence on carriers, conducting feasibility studies to determine the viability to be a stop-loss carrier on the platform, negotiating terms and contracts, coordinating audit requests, managing relationship with unrelated carriers and their regulators and auditor firms to ensure that our risk associated with our service offerings is minimized. Sales and marketing expenses Sales and marketing expenses primarily consist of personnel-related costs including salaries, stock-based compensation expense, benefits and commissions cost for our sales and marketing personnel. Sales and marketing expenses also include the costs for advertising, promotional and other marketing activities, as well as certain fees paid to various third-party for sales and customer acquisition. General and administrative expenses General and administrative expenses primarily consist of personnel-related costs and related expenses for our executives, finance, legal, human resources, technical support, and administrative personnel as well as the costs associated with professional fees for external legal, accounting and other consulting services, insurance premiums. Research and development expenses Research and development expenses primarily consist of personnel-related costs, including salaries, stock-based compensation expense and benefits for our research and development personnel. Additional expenses include costs related to the software development, quality assurance, and testing of new technology, and enhancement of our existing platform technology. Adjusted EBITDA Adjusted EBITDA represents our net income before net interest expense, taxes, and depreciation and amortization expense, adjusted to eliminate stock-based compensation expense. Adjusted EBITDA is not a measure calculated in accordance with United States Generally Accepted Accounting Principles, or GAAP. We exclude certain non-recurring or non-cash items when calculating Adjusted EBITDA, and we believe this approach provides a more meaningful measure by offering a clearer view of our underlying operational performance. Financial Results Summary (Unaudited） ($ in millions) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 % Change 2025 2024 % Change Total revenues $ 8.5 $ 4.5 90.4 % $ 25.8 $ 14.6 77.0 % GAAP gross margin 60.6 % 78.0 % -17.4 % $ 65.1 % $ 79.8 % -14.7 % Income before income tax expense $ 0.6 $ 0.4 47.6 % $ 2.1 $ 1.0 111.8 % Adjusted EBITDA $ 1.0 $ 0.7 49.4 % $ 3.8 $ 1.8 110.2 % Investor ContactInvestor Relations:ir@healthintech.com
美國總統 Donald J. Trump 以榮譽嘉賓身份在座無虛席的 Kaseya Center 發表演說 星級陣容包括：Jeff Bezos、Lionel Messi、Rafael Nadal、阿根廷總統 Javier Milei、Tony Robbins、Serena Williams、Jamie Dimon、Ken Griffin、María Corina Machado、Stefano Domenicali、Gianni Infantino、沙地阿拉伯駐美國大使 Reema Bandar Al-Saud、Eric Schmidt、Steve Witkoff、Patrick Bet-David、Adam Neumann 以及 Fahad Alsaif. 邁阿密2025年11月11日 /美通社/ -- 11 月 5 日至 6 日，America Business Forum: Miami 在座無虛席的卡西亞中心召開，匯聚全球最具影響力的體育、政治、商業及文化領袖，共同參與這場歷史性盛會，並透過直播向全球觀眾呈現。 以「世界在美國相遇」(The World Meets in America) 為主題，演講者們分享的見解分析超越了業界和國界的樊籬，並重塑了商業、文化與地緣政治的未來。 「首屆 America Business Forum: Miami 是一場非凡盛會，將全球領導者與世界各地的觀眾聯繫起來，」America Business Forum 董事會主席 Francis Suárez 表示：「我們向與我們一起創造歷史的傑出演講者、贊助商以及每一位與我們一起創造歷史的與會者，致以感謝之情。」 「America Business Forum: Miami 為體育，商業，政治和文化方面的下一步設定了議程，」America Business Forum 創辦人 Ignacio Gonzalez 表示：「Kaseya Center 內的能量非常強大，因為地球上最偉大的遠見者分享對未來的見解，反思其旅程並提供建議。能在此邁阿密，讓全球頂尖領袖齊聚一堂，實屬榮幸。」 該活動由 Fox News 的 Bret Baier 主持，PIF 擔任活動主協辦單位。 講者的重要時刻： Donald J. Trump，美國第 45 任及第 47 任總統 Javier Milei，阿根廷總統 Jeff Bezos，Amazon 與 Blue Origin 創辦人 Lionel Messi，世界足球冠軍 Rafael Nadal，世界網球偶像和企業家 Tony Robbins，美國首屈一指的生活和商業策略家 Serena Williams，專業運動員和企業家 Jamie Dimon，JPMorgan Chase 董事長兼行政總裁 Ken Griffin，Citadel 創辦人兼行政總裁 María Corina Machado， 2025 年諾貝爾和平獎 (Nobel Peace Prize) 得主 Stefano Domenicali ，F1 董事長兼行政總裁 Gianni Infantino，國際足聯 (FIFA) 董事長 沙地阿拉伯駐美國大使 Reema Bandar Al-Saud Eric Schmidt，Relativity Space 董事長兼行政總裁；前 Google 董事長兼行政總裁 Steve Witkoff，The Witkoff Group 創辦人兼行政總裁，另兼美國中東問題特使 Patrick Bet-David，Valuetainment 播客主持人 Adam Neumann，WeWork 與 Flow 的共同創辦人 Fahad Alsaif，PIF 投資策略與經濟分析主管 請密切留意：Instagram：@AmericaBusinessLinkedIn：America Businesswww.americabusiness.com 僅供編輯使用的照片：2025 年 11 月 5 日2025 年 11 月 6 日 關於America Business Forum：America Business 是全球領袖的首要峰會，匯聚來自政府、商界與文化領域的地球上最具影響力的人物。此論壇打造對話、啟發與行動的交流平台，驅動個人與機構創造突破性創新，共同塑造未來。
DUBLIN and STAMFORD, Conn. and NEW YORK, Nov. 11, 2025 /PRNewswire/ -- Phoenix Aviation Capital ("Phoenix" or "the Company"), a full-service aircraft lessor managed by AIP Capital ("AIP"), an alternative investment manager focused on opportunities in asset-based finance and a portfolio company of funds advised or controlled by affiliates of BC Partners Advisors L.P., announced the issuance of a $592 million term loan facility ("term loan"). Phoenix and AIP intend on using proceeds from the term loan to repay existing warehouse debt and finance future growth. Morgan Stanley, Citi, and RBC Capital Markets acted as Joint Lead Arrangers and Joint Bookrunners with Morgan Stanley also acting as Administrative Agent and Collateral Agent. Since the beginning of 2025, Phoenix has raised over $2 billion in bank and institutional capital to support Phoenix's growth strategy. "The issuance of this term loan facility provides Phoenix with longer-term flexibility as it continues to grow its portfolio of in-demand aviation assets," said Jared Ailstock, Managing Partner at AIP. "We also believe the issuance of this facility demonstrates further confidence in Phoenix's strategy among Phoenix's lending counterparties." "This issuance reflects another key milestone in Phoenix's execution of its strategy of growing its fleet of next-generation aircraft assets," said Patrick Schafer, Partner at BC Partners and board member of Phoenix. "The facility will provide Phoenix with additional capacity and flexibility to execute on this strategy." Clifford Chance served as transaction counsel and PwC acted as tax advisor to Phoenix and AIP. McCann Fitzgerald also acted in capacity as Irish counsel to Phoenix and AIP. Pivotal Corporate provided corporate services assistance to Phoenix and AIP. Cahill Gordon & Reindel LLP served as transaction counsel to the lenders. About Phoenix Aviation CapitalPhoenix Aviation Capital is a full-service aircraft lessor focused on financing modern, in-demand aircraft and is dedicated to meeting the financing needs of its airline customers across the globe. Phoenix Aviation Capital is based in Dublin and is managed by AIP Capital, a global aviation asset management and investment firm. For more information about Phoenix Aviation Capital or to speak with company executives, please contact investor.relations@phoenixaviationcap.com. About AIP CapitalAIP Capital (AIP) is a global alternative investment manager focused on opportunities in asset-based finance including aviation and equipment finance. AIP, together with its affiliates, manages approximately $4 billion of assets on behalf of a diversified global investor base. The AIP team is comprised of more than 50 experienced professionals across AIP's offices in Stamford, New York City, Dublin, and Singapore. For more information about AIP Capital or to speak with company executives, please contact investor.relations@aipcapital.com. About BC Partners & BC Partners CreditBC Partners is a leading international investment firm in private equity, private debt, and real estate strategies. BC Partners Credit was launched in February 2017, with a focus on identifying attractive credit opportunities in any market environment, often in complex market segments. The platform leverages the broader firm's deep industry and operating resources to provide flexible financing solutions to middle-market companies across Business Services, Industrials, Healthcare and other select sectors. For further information, visit www.bcpartners.com/credit-strategy. Media Contacts AIP Capital Geoffrey Bayersinvestor.relations@aipcapital.com BC PartnersLuke CharalambousLuke.Charalambous@BCPartners.com+44 7775 180 721
KANSAS CITY, Mo., Nov. 11, 2025 /PRNewswire/ -- Lockton, the world's largest privately held independent insurance brokerage, has announced the firm's expansion into the Kingdom of Saudi Arabia, further strengthening its presence across the Middle East. This move is part of Lockton's broader international strategy to ensure proximity to clients and deliver tailored insurance solutions in high-growth markets. Mohammad Al Abdul Jabbar Across its global footprint, Lockton has strategically expanded operations to meet the evolving needs of clients in key regions. The Middle East is a cornerstone of this strategy, with the firm continuing to invest in local leadership, capabilities, and technology to support businesses navigating evolving risk environments. The decision to enter Saudi Arabia reflects the Kingdom's growing role as a regional economic powerhouse. With increasing demand for insurance and risk advisory services across industries such as construction, energy, healthcare, and financial services, Lockton's presence will offer clients enhanced access to global expertise, delivered through a local lens. Lockton's Saudi Arabia retail operation launches with a team of 20 specialists and insurance and risk advisors, ensuring clients will benefit from both global best practices and local market understanding. As part of this expansion, Mohammad Al Abdul Jabbar has been appointed as CEO for Lockton's retail operations in Saudi Arabia. A seasoned insurance executive, Al Abdul Jabbar brings more than two decades of experience across both insurance broking and underwriting, having held senior leadership roles at leading insurance brokers as well as local insurers. His career spans the full spectrum of the insurance value chain, from underwriting commercial lines and Takaful, to leading regional business development and managing complex insurance and risk portfolios for multinational clients. Al Abdul Jabbar also serves as vice chairman of the executive committee of the General Committee of Insurance & Reinsurance Brokers in Saudi Arabia, reflecting his deep industry involvement and commitment to advancing the sector. "Saudi Arabia is a critical market for Lockton and our expansion here reflects our long-term commitment to the region and our clients," said Faris Khatib, CEO of Lockton Middle East and North Africa. "Mohammad's appointment brings a strong combination of broking and underwriting expertise, deep market knowledge and a client-first mindset. His leadership will be instrumental in building our operations and delivering value to clients across the Kingdom." "Lockton's growth is driven by our belief in being where our clients need us most," said Chris Brown, CEO of Lockton International. "Expanding into Saudi Arabia allows us to support businesses in one of the world's most dynamic economies. We are thrilled to welcome Mohammad to our leadership team; his experience and entrepreneurial spirit align perfectly with Lockton's culture and our ambition to be the most client-focused insurance broker globally." About Lockton Lockton's private ownership empowers its 13,100+ Associates doing business in more than 155+ countries to focus solely on clients' risk and insurance needs. With expertise that reaches around the globe, Lockton delivers the deep understanding needed to accomplish remarkable results. For more information, visit www.lockton.com. (from right): Mohammad Al Abdul Jabbar, CEO of Lockton Saudi Arabia; Khalid Al Deghaither, Vice President of Compliance; Naji A Tamimi, CEO of the Insurance Authority; Faris Khatib, CEO of Lockton Middle East and North Africa; Ata Khatib, Chairman of Lockton Middle East and North Africa; and two representatives of the Insurance Authority.
A12 藝術空間
D-Link
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
